Also, oesophageal cancer patients with both HLA-A24-positive and HER-2-positive tumours accounted for 26% of these cases, and both HLA-A2-positive and HER-2-positive tumours accounted for 18% of them. This evidence concerns the gene ERBB2 and neoplasm.